In medical image analysis, AI can surpass human experts; in diabetes it can raise an alarm in time to head off a glycaemic event. Hints of its power, but concerns about privacy are slowing deployment of AI tools
Many adults with diabetes are unaware of their increased risk for certain serious illnesses, including pneumococcal pneumonia/pneumococcal disease, flu and hepatitis B, according to a recent national online survey sponsored by Merck & Co. (known as MSD in Europe) and the American Diabetes Association.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.